Concepedia

Roberto Guerciolini

RG

31

Publications

2.7K

Citations

21

H-Index

1985

Active since

Affiliations

La Roche College(Current)

University of Perugia

Roche (Switzerland)

University of Colorado Health

Millennium Engineering and Integration (United States)

Roberto Guerciolini is an author at La Roche College specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1985–2017

31

Publications

31

Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell et al. · Journal of Clinical Oncology · 2002 · 760 citations

Mode of action of orlistat.

Roberto Guerciolini · PubMed · 1997 · 327 citations

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

Jianguo Zhi, Angela T. Melia, Roberto Guerciolini et al. · Clinical Pharmacology & Therapeutics · 1994 · 280 citations

Phase I Study of Bortezomib in Refractory or Relapsed Acute Leukemias

Jörge E. Cortes, Deborah A. Thomas, Charles Koller et al. · Clinical Cancer Research · 2004 · 198 citations

RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027

Peter K. Kaiser, R. C. Andrew Symons, Syed Mahmood Shah et al. · American Journal of Ophthalmology · 2010 · 188 citations

, , +2

Rows per page

1–5 of 31